Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04068896
Title Study of NGM120 in Subjects With Advanced Solid Tumors and Pancreatic Cancer Using Combination Therapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors NGM Biopharmaceuticals, Inc
Indications

stomach cancer

melanoma

colorectal cancer

pancreatic cancer

esophageal cancer

lung non-small cell carcinoma

urinary bladder cancer

head and neck squamous cell carcinoma

ovarian cancer

pancreatic adenocarcinoma

prostate cancer

Therapies

NGM120

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.